JNJ - Manufacturing snafu ruins 15M J&J vaccine doses - New York Times

Human error led to the accidental mixing of vaccines at an Emergent BioSolutions (EBS) plant in Baltimore, rendering 15M doses of Johnson & Johnson's (JNJ) COVID-19 vaccine useless, The New York Times reports.Workers at the facility, which also manufactures AstraZeneca's (AZN) COVID-19 vaccine, mistakenly combined the two vaccines' ingredients.The snafu has stopped future shipments of the J&J vaccine as the FDA launches an investigation.J&J doses that are currently being administered are not impacted as they were manufactured in the Netherlands.Emergent came under fire earlier this month after a news report cited federal contracts the company received for the Strategic National Stockpile.Emergent shares are down 4.2% to $88.99 and J&J shares are down 0.2% to $164 in after-hours trading.

For further details see:

Manufacturing snafu ruins 15M J&J vaccine doses - New York Times